Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus
Autoimmune disorder is a chronic immune imbalance which is developed through a series of pathways. The defect in B cells, T cells, and lack of self-tolerance has been greatly associated with the onset of many types of autoimmune complications including rheumatoid arthritis, systemic lupus erythemato...
Guardado en:
Autores principales: | Ghulam Mustafa, Hafiza Salaha Mahrosh, Mahwish Salman, Sumaira Sharif, Raheela Jabeen, Tanveer Majeed, Hafsah Tahir |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4830ee3a4ac4b369b51142de47800c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients
por: Yasmin Adel, et al.
Publicado: (2020) -
Dynamics of TNF-α and IFN-γ in adult patients with measles depending on the development of complications
por: S. O. Bilokobyla, et al.
Publicado: (2021) -
Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011) -
Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus
por: Gro Østli Eilertsen, et al.
Publicado: (2021) -
IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis
por: Nehal N. Mehta, et al.
Publicado: (2017)